Pediatric Annals (Pediatr Ann)

Publisher: Slack

Journal description

Pediatric Annals is America's most widely read journal for continuing education in the field of pediatrics. Each monthly issue provides a thorough, practical review of a single topic in pediatrics, carefully chosen by an editorial board composed of the leading pediatricians in the United States. Three credit hours in Category 1 for the Physician's Recognition Award of the AMA are offered for the successful completion of a CME quiz.

Current impact factor: 0.29

Impact Factor Rankings

2015 Impact Factor Available summer 2015
2013 / 2014 Impact Factor 0.288
2012 Impact Factor 0.303
2011 Impact Factor 0.484
2010 Impact Factor 0.503
2009 Impact Factor 0.369
2008 Impact Factor 0.541
2007 Impact Factor 0.724
2006 Impact Factor 0.741
2005 Impact Factor 0.383
2004 Impact Factor 0.374
2003 Impact Factor 0.318
2002 Impact Factor 0.223
2001 Impact Factor 0.383
2000 Impact Factor 0.739
1999 Impact Factor 0.459
1998 Impact Factor 0.355
1997 Impact Factor 0.31

Impact factor over time

Impact factor
Year

Additional details

5-year impact 0.40
Cited half-life 8.40
Immediacy index 0.06
Eigenfactor 0.00
Article influence 0.13
Website Pediatric Annals website
Other titles Pediatric annals
ISSN 0090-4481
OCLC 1772141
Material type Periodical
Document type Journal / Magazine / Newspaper

Publisher details

Slack

  • Pre-print
    • Author cannot archive a pre-print version
  • Post-print
    • Author cannot archive a post-print version
  • Restrictions
    • 12 months embargo
  • Conditions
    • On Institutional Repositories
    • Publisher's version/PDF cannot be used
    • NIH authors may deposit in PubMed Central after 12 months
    • Must link to publisher version
  • Classification
    ‚Äč white

Publications in this journal

  • [Show abstract] [Hide abstract]
    ABSTRACT: A 14-year-old boy presented with months of severe widespread musculoskeletal pain. He was profoundly fatigued and unable to attend school. Laboratory evaluation, including complete blood count, comprehensive metabolic panel, inflammatory markers, and thyroid function, was unrevealing. Physical examination was also normal except for multiple tender points. The patient was diagnosed with juvenile primary fibromyalgia syndrome and referred for multidisciplinary treatment including physical therapy, exercise, and counseling, and his daily functioning gradually improves. Juvenile fibromyalgia is a complex syndrome that often severely limits patients' activities and can impede normal adolescent development. Effective treatment requires an understanding of the biologic, psychologic, and social factors contributing to the perpetuation of chronic pain. The author reviews the diagnostic criteria, pathophysiology, and treatment of juvenile fibromyalgia. Medications, particularly antidepressants and anticonvulsants, can be useful adjuncts to therapy. However, multimodal pain management including intensive physical therapy, exercise, counseling, and sleep hygiene is most effective in treating fibromyalgia. [Pediatr Ann. 2015;44(6):e136-e141.]. Copyright 2015, SLACK Incorporated.
    Pediatric Annals 06/2015; 44(6):e136-e141. DOI:10.3928/00904481-20150611-08
  • Pediatric Annals 06/2015; 44(6):216-217. DOI:10.3928/00904481-20150611-01
  • [Show abstract] [Hide abstract]
    ABSTRACT: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by the presence of antinuclear antibodies and other autoantibodies, as well as a clinical course that is characterized by flares and remissions. The clinical presentation is diverse, ranging from a mild disease characterized by rash and arthritis to a severe life-threatening disease involving multiple organs. Approximately 25% of children with SLE have neuropsychiatric manifestations of SLE, which are a major cause of morbidity and mortality. Neuropsychiatric symptoms may be the initial presentation of SLE in children. The mortality rate is relatively low, but morbidity may be significant and permanent damage can occur. This article discusses the importance, known pathophysiologic mechanisms, clinical approach, and evidence-based therapeutic options for the diagnosis and management of neuropsychiatric lupus erythematosus in children and adolescents. [Pediatr Ann. 2015;44(6):e153-e158.]. Copyright 2015, SLACK Incorporated.
    Pediatric Annals 06/2015; 44(6):e153-e158. DOI:10.3928/00904481-20150611-11
  • Pediatric Annals 06/2015; 44(6):236-237. DOI:10.3928/00904481-20150611-05
  • Pediatric Annals 06/2015; 44(6):238-239. DOI:10.3928/00904481-20150612-06
  • Pediatric Annals 06/2015; 44(6):232-234. DOI:10.3928/00904481-20150611-04
  • [Show abstract] [Hide abstract]
    ABSTRACT: A 15-year-old girl presented with knee pain, associated with a positive antinuclear antibody (ANA). She denied joint swelling or morning stiffness and remained physically active despite the pain. A physical examination was unremarkable except for articular hypermobility. Laboratory results were also unremarkable. Therefore, the positive ANA was determined to be nonspecific, and not concerning. In the evaluation of children with musculoskeletal complaints, unusual rash, or fatigue, an ANA assessment is frequently considered. When is this test most likely to be useful? What is the appropriate follow up for a positive result? Which results are concerning for an autoimmune process? This article reviews the literature to address these practical concerns. Understanding the indications for ordering an ANA, and the correct interpretation of a positive ANA, may reduce unnecessary referrals and costly tests. Moreover, the misperception that a positive ANA indicates a rheumatologic disease can cause significant patient and parental anxiety. [Pediatr Ann. 2015;44(6):e131-e135.]. Copyright 2015, SLACK Incorporated.
    Pediatric Annals 06/2015; 44(6):e131-e135. DOI:10.3928/00904481-20150611-07
  • [Show abstract] [Hide abstract]
    ABSTRACT: Systemic juvenile idiopathic arthritis (sJIA) is characterized by a large range of extra-articular manifestations in addition to joint inflammation. The child with sJIA usually presents with a spiking fever pattern, evanescent rash, and arthralgias/arthritis. Other features often present are lymphadenopathy, hepatosplenomegaly, and polyserositis. The systemic manifestations are frequently more prominent and severe than the arthritis. Laboratory studies reflect systemic inflammation with significant anemia, and elevation of acute phase reactants, platelets, and white blood cell count. Ferritin level is often strikingly high. The treatment of sJIA has evolved over the past decade with the improved understanding of the role of specific inflammatory cytokines in this disease. The medications employed to treat sJIA directly inhibit the actions of these cytokines. A major cause of morbidity and mortality of children with sJIA is the development of macrophage activation syndrome, which can cause unremitting fevers, pancytopenia, coagulopathy, and hepatic dysfunction. [Pediatr Ann. 2015;44(6):e142-e147.]. Copyright 2015, SLACK Incorporated.
    Pediatric Annals 06/2015; 44(6):e142-e147. DOI:10.3928/00904481-20150611-09
  • [Show abstract] [Hide abstract]
    ABSTRACT: I remember the morning we discovered we were expecting our second child. I was a second-year pediatric resident starting my rotation in the pediatric intensive care unit. I had just given birth to our first child 14 months earlier and was still overwhelmed, yet amazed, by the process of becoming a parent. Certainly we had always hoped for more than one child but this one was coming 9 months sooner than our grand plan. Being an older, nontraditional medical student, I was already significantly older than my colleagues in residency. I wondered anxiously how I was going to explain to my residency director and my fellow residents, who so graciously covered for me on my first maternity leave, that I was pregnant, yet again. Thankfully, 9 months later our second son was born healthy and vigorous. In those long, yet short 9 months, we discovered that our material needs would drastically change. We contemplated a new car that would accommodate two car seats safely and comfortably, and anticipated finding the room, in an already cramped living space, for both a toddler bed and a crib. Perhaps most important at the time, our nanny, who already did a wonderful job of caring for our eldest child, happily accepted the opportunity to now take care of both our children, at an additional cost. [Pediatr Ann. 2015;44(6):224-227.]. Copyright 2015, SLACK Incorporated.
    Pediatric Annals 06/2015; 44(6):224-227. DOI:10.3928/00904481-20150611-03
  • [Show abstract] [Hide abstract]
    ABSTRACT: Takayasu's arteritis (TA) is a granulomatous, large vessel vasculitis affecting primarily the aorta and its main branches. It is characterized by inflammation in the blood vessel wall, leading to either luminal occlusion or dilatation with aneurysm formation. The etiology of TA is unknown, but there seems to be a strong role for cell-mediated autoimmunity in the pathogenesis of this disease. TA most commonly presents in young women in their second and third decades of life, but has been reported in children as young as age 2 years. The symptoms can range from vague systemic complaints to catastrophic stroke. Angiography remains the gold standard for diagnosis, although computed tomography angiography and magnetic resonance angiography have been used as well. Corticosteroids are first-line therapy, with various cytotoxic medications being used in refractory disease. Biologic agents targeting cytokines that are involved in disease pathogenesis have also been used successfully. In this article, we describe a patient with TA who responded to therapy with infliximab, an inhibitor of tumor necrosis factor. [Pediatr Ann. 2015;44(6):e148-e152.]. Copyright 2015, SLACK Incorporated.
    Pediatric Annals 06/2015; 44(6):e148-e152. DOI:10.3928/00904481-20150611-10
  • Pediatric Annals 06/2015; 44(6):218-222. DOI:10.3928/00904481-20150611-02
  • [Show abstract] [Hide abstract]
    ABSTRACT: Congenital syphilis (CS) is a disease that continues to persist in the United States despite its preventable nature. Mother-to-child transmission of CS can be avoided with appropriate maternal diagnosis and treatment during the pregnancy. Diagnosing CS and determining the therapeutic course can be challenging. This review covers the recent guidelines for the diagnosis and treatment of CS and the various factors that affect management decisions. These factors include the mother's antenatal management, the infant's clinical presentation and results, laboratory and serologic testing, and more. [Pediatr Ann. 2015;44(5):e108-e114.]. Copyright 2015, SLACK Incorporated.
    Pediatric Annals 05/2015; 44(5):e108-14. DOI:10.3928/00904481-20150512-10
  • Pediatric Annals 05/2015; 44(5):192-194. DOI:10.3928/00904481-20150512-05
  • Pediatric Annals 05/2015; 44(5):198-9. DOI:10.3928/00904481-20150512-07
  • Pediatric Annals 05/2015; 44(5):174-175. DOI:10.3928/00904481-20150512-02
  • [Show abstract] [Hide abstract]
    ABSTRACT: There are currently 12 species and over 100 serotypes that have been identified in the enterovirus genus, including the coxsackieviruses, echoviruses, and polioviruses. Since their discovery 65 years ago, much has been discovered and continues to be researched regarding the pathogenicity and scope of disease of nonpolio enteroviruses. Like many infections, enteroviruses have been found to affect neonates much differently, and often more severely, than older children and adults. Neonatal infections often cause mild illnesses with nonspecific symptoms, but they may also have severe presentations involving the cardiovascular, gastrointestinal, hematologic, or central nervous systems. This article provides an overview of what is known about nonpolio enteroviruses in neonates including epidemiology, transmission, clinical presentation, diagnosis, and treatment. [Pediatr Ann. 2015;44(5):e103-e107.]. Copyright 2015, SLACK Incorporated.
    Pediatric Annals 05/2015; 44(5):e103-7. DOI:10.3928/00904481-20150512-09
  • Pediatric Annals 05/2015; 44(5):195-197. DOI:10.3928/00904481-20150512-06
  • [Show abstract] [Hide abstract]
    ABSTRACT: With the current prevalence of celiac disease, it is important to know the common signs and symptoms of this disease process and to also be aware of atypical presentations. This article describes a toddler who initially presented with recurrent diarrhea and weight loss with a significant secondary hypokalemia. His initial examination included screening for celiac disease, but the serology was negative. After persistent and worsening symptoms, further tests were pursued and a diagnosis of celiac disease was confirmed based on an upper endoscopy and histology. [Pediatr Ann. 2015;44(5):210-212.]. Copyright 2015, SLACK Incorporated.
    Pediatric Annals 05/2015; 44(5):210-2. DOI:10.3928/00904481-20150512-13
  • Pediatric Annals 05/2015; 44(5):180-183. DOI:10.3928/00904481-20150512-03